California
Duarte; City of Hope
CTSU/ECOG E2805: A Randomized, Double-Blind Phase III Trial of Adjuvant Sunitinib versus Sorafenib versus Placebo in Resected Renal Cell Carcinoma
Duarte; Research Site
A Phase 2 study of SU011248 in the treatment of patients with Bevacizumab-refractory Metastatic renal cell carcinoma.
San Francisco; Research Site
A Phase 2 study of SU011248 in the treatment of patients with Bevacizumab-refractory Metastatic renal cell carcinoma.
Florida
Gainesville; Gainesville Hematology/ Oncology Associates
A Randomized Phase II Study Of The Efficacy And Safety of Sunitinib Malate Schedule Four Weeks On And Two Weeks Off Versus Sunitinib Malate Continuous Dosing As First-Line Therapy For Metastatic Renal Cell Cancer (RENAL EFFECT TRIAL)
Illinois
Chicago; Research Site
A Phase 2 study of SU011248 in the treatment of patients with Bevacizumab-refractory Metastatic renal cell carcinoma.
Indiana
Indianapolis; American Health Network of Indiana LLC, Oncology Division
A phase III trial of study drug and ARA-C for patients with AML in first relapse.
Indianapolis; American Health Network of Indiana LLC, Oncology Division
Phase II trial of 2 dose levels of study drug in patients with metastatic or locally recurrent clear cell renal carcinoma
Massachusetts
Boston; Research Site
A Phase 2 study of SU011248 in the treatment of patients with Bevacizumab-refractory Metastatic renal cell carcinoma.
New York
Manhasset; Biomedical Research Alliance of New York, LLC
Study for high risk recurrence of renal cell carcinoma after surgical treatment
Manhasset; Biomedical Research Alliance of New York
A clinical trial evaluate the safety and efficacy of a study drug versus placebo in patients with a clear renal cell carcinoma and a high risk of recurrence
Manhasset; Biomedical Research Alliance of New York
A clinical trial evaluate the safety and efficacy of a study drug versus placebo in patients with a clear cell renal cell carcinoma and a high risk of recurrence
New York; Mount Sinai Medical Center
A Multi-Center, Randomized Phase III Study of Adjuvant Oncophage? Versus Observation in Subjects With High Risk of Recurrence After Surgical Treatment for Renal Cell Carcinoma.
New York; Biomedical Research Alliance of New York
A clinical trial evaluate the safety and efficacy of a study drug versus placebo in patients with a clear cell renal cell carcinoma and a high risk of recurrence
North Carolina
Durham; Research Site
A Phase 2 study of SU011248 in the treatment of patients with Bevacizumab-refractory Metastatic renal cell carcinoma.
Ohio
Cleveland; Research Site
A Phase 2 study of SU011248 in the treatment of patients with Bevacizumab-refractory Metastatic renal cell carcinoma.
Tennessee
Nashville; Research Site
A Phase 2 study of SU011248 in the treatment of patients with Bevacizumab-refractory Metastatic renal cell carcinoma.
Virginia
Charlottesville; University of Virginia
Children with Chronic Renal Insufficiency and taking Growth Hormone are needed for a research study
